This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Korea Institute of Machinery & Materials. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations of Soon-Chan Hwang in Intravenous Infusion Technology.
Introduction
Soon-Chan Hwang is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of medical technology, particularly in the area of intravenous infusion systems. His innovative approach addresses critical challenges in regulating flow rates for intravenous solutions.
Latest Patents
Hwang holds a patent for a "Linear flow regulating apparatus for intravenous infusion." This invention relates to a flow regulating apparatus used in infusion sets to control the flow rate of solutions injected into the body. The design aims to overcome the limitations of conventional flow regulating devices, which often rely on pressing a solution flow tube to adjust the flow passage area. Hwang's apparatus features a control unit that can be adjusted along the width of a fixed flow channel unit, allowing for linear regulation of the flow rate by varying the flow passage area.
Career Highlights
Hwang is affiliated with the Korea Institute of Machinery and Materials, where he continues to engage in research and development. His work focuses on enhancing medical devices to improve patient care and treatment outcomes. His innovative solutions have the potential to significantly impact the medical field.
Collaborations
Hwang has collaborated with esteemed colleagues, including Eui-Soo Yoon and Moo-Ryong Park. Their combined expertise contributes to the advancement of technology in the medical sector.
Conclusion
Soon-Chan Hwang's contributions to intravenous infusion technology exemplify the importance of innovation in healthcare. His patent for a linear flow regulating apparatus showcases his commitment to improving medical devices for better patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile